Review

The New Generation of Beta-Cells: Replication, Stem Cell Differentiation, and the Role of Small Molecules

Malgorzata Borowiak

Manuscript submitted June 21, 2010; resubmitted July 18, 2010; accepted July 30, 2010.

Keywords: stem cell, induced pluripotent, embryonic day, transcription factor, definite endoderm, diabetes, transplantation, Pdx1, beta-cell, growth factor

Abstract

Diabetic patients suffer from the loss of insulin-secreting β-cells, or from an improper working β-cell mass. Due to the increasing prevalence of diabetes across the world, there is a compelling need for a renewable source of cells that could replace pancreatic β-cells. In recent years, several promising approaches to the generation of new β-cells have been developed. These include directed differentiation of pluripotent cells such as embryonic stem (ES) cells or induced pluripotent stem (iPS) cells, or reprogramming of mature tissue cells. High yield methods to differentiate cell populations into β-cells, definitive endoderm, and pancreatic progenitors, have been established using growth factors and small molecules. However, the final step of directed differentiation to generate functional, mature β-cells in sufficient quantities has yet to be achieved in vitro. Beside the needs of transplantation medicine, a renewable source of β-cells would also be important in terms of a platform to study the pathogenesis of diabetes, and to seek alternative treatments. Finally, by generating new β-cells, we could learn more details about pancreatic development and β-cell specification. This review gives an overview of pancreas ontogenesis in the perspective of stem cell differentiation, and highlights the critical aspects of small molecules in the generation of a renewable β-cell source. Also, it discusses longer term challenges and opportunities in moving towards a therapeutic goal for diabetes.

Fulltext: HTML , PDF (256KB)

This article has been cited by other articles:

	Stemistry: The Control of Stem Cells in Situ Using Chemistry Davies SG, Kennewell PD, Russell AJ, Seden PT, Westwood R, Wynne GM J Med Chem 2015. In press
	The temporal and hierarchical control of transcription factors-induced liver to pancreas transdifferentiation Berneman-Zeitouni D, Molakandov K, Elgart M, Mor E, Fornoni A, Domínguez MR, Kerr-Conte J, Ott M, Meivar-Levy I, Ferber S Plos One 2014. 9(2):e87812
	Modeling the blood-brain barrier using stem cell sources Lippmann ES, Al-Ahmad A, Palecek SP, Shusta EV Fluids Barriers CNS 2013. 10(1):2
	Position Statement of the Chinese Diabetes Society regarding stem cell therapy for diabetes Zhu D, Chen L, Hong T, Chinese Diabetes Society J Diabetes 2012. 4(1):18-21
	Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype Zanini C, Bruno S, Mandili G, Baci D, Cerutti F, Cenacchi G, Izzi L, Camussi G, Forni M PLoS One 2011. 6(12):e28175
	Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols Liew CG Rev Diabet Sud 2010. 7(2):82-92